Marella Thorell - 13 Dec 2022 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Issuer symbol
GRI
Transactions as of
13 Dec 2022
Net transactions value
$0
Form type
4
Filing time
15 Dec 2022, 15:26:39 UTC
Previous filing
01 Sep 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRI Common Stock Other $0 -28,517 -75% $0.000000 9,506 13 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cancellation of unvested restricted stock units granted on July 1, 2022.